导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | 1.54% | 2462/4982 |
| 近一周 | -3.96% | 4928/5419 |
| 近一月 | -1.71% | 1671/5423 |
| 近一季 | -7.72% | 2690/5376 |
| 近半年 | -7.88% | 3401/5131 |
| 近一年 | 1.94% | 2540/4741 |
| 近两年 | 55.25% | 2107/4208 |
| 近三年 | 18.27% | 2340/3661 |
| 成立以来 | 264.68% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
3.68% 975/5130 |
7.25% 2895/5464 |
- - |
- - |
| 2025 | 16.27% 3505/5130 |
6.54% 1296/4624 |
-4.80% 4370/4802 |
16.78% 3295/4970 |
-1.83% 2600/5130 |
| 2024 | 1.37% 2381/4618 |
-8.04% 3249/4340 |
-8.74% 3833/4442 |
16.90% 599/4550 |
3.33% 831/4618 |
| 2023 | -11.68% 1299/4216 |
4.29% 1190/3759 |
-7.35% 2861/3909 |
-8.10% 2092/4055 |
-0.53% 594/4209 |
| 2022 | -21.80% 1412/3578 |
-18.87% 1671/2804 |
9.95% 985/3205 |
-18.20% 2868/3430 |
7.17% 418/3570 |
| 2021 | 26.33% 211/2717 |
-3.61% 818/1745 |
18.53% 404/2232 |
2.07% 512/2560 |
8.33% 304/2708 |
| 2020 | 50.47% 602/1596 |
2.00% 278/1036 |
17.44% 798/1256 |
12.59% 464/1472 |
11.57% 953/1690 |
| 2019 | 24.34% 606/926 |
19.10% 1454/3054 |
-7.92% 2858/3201 |
3.33% 613/939 |
9.73% 386/1014 |
| 2018 | -23.26% 246/668 |
- - |
- - |
- - |
-10.36% 2026/2977 |
| 2017 | 18.72% 184/531 |
- - |
- - |
- - |
- - |
| 2016 | -4.52% 87/455 |
- - |
- - |
- - |
- - |
| 2015 | 51.48% 174/433 |
- - |
- - |
- - |
- - |
| 2014 | 17.89% 276/432 |
- - |
- - |
- - |
- - |
| 2013 | 19.86% 134/398 |
- - |
- - |
- - |
- - |
| 2012 | -0.91% 383/459 |
- - |
- - |
- - |
- - |
| 2011 | -31.72% 361/392 |
- - |
- - |
- - |
- - |
| 2010 | 21.97% 14/335 |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商品质成长混合C | 1.0027 | 56.52% |
| 招商创新增长混合A | 1.0759 | 55.91% |
| 招商创新增长混合C | 1.0235 | 55.61% |
| 招商品质成长混合A | 1.0435 | 55.01% |
| 华泰柏瑞医疗健康A | 2.6422 | 50.99% |
| 华泰柏瑞医疗健康C | 2.5804 | 49.15% |
| 大摩优悦安和混合A | 0.8994 | 48.05% |
| 大摩优悦安和混合C | 0.8828 | 47.91% |
| 中信建投医药健康A | 0.7950 | 39.62% |
| 中信建投医药健康C | 0.7579 | 39.35% |
| 大摩领先优势混合 VS. 长安宏观策略混合A(740001) |